The revision reflects Moody’s expectation that the district’s margins will remain pressured after weaker profitability in fiscal year 2018 and relatively high debt, along with a highly competitive market.
Moody’s also affirmed its “Baa1” rating on outstanding revenue bonds.
More articles on healthcare finance:
Navigant Managing Director Tim Kinney on navigating revenue cycle technology challenges
Upgraded digital payment tools not a priority for most healthcare providers, survey finds
Zuckerberg hospital considers cost cap for privately insured patients amid billing uproar
